Hannah P. Kuschman, Ph.D., is a technical specialist in Sterne Kessler’s Biotechnology & Chemical Practice Group where she assists in writing and prosecuting U.S. and foreign patent applications. Hannah’s technical areas of expertise include molecular biology, medicinal chemistry, redox biology, and oncology.

Hannah received her Ph.D. from the College of Pharmacy at University of Illinois at Chicago. Her graduate research focused on investigating the effect of nitric oxide, a free radical gasotransmitter, on epigenetic modifications and its relevance in cancer. Using a diverse set of molecular biology methods including epigenetic immunoprecipitation combined with next-generation sequencing, Hannah identified a novel subset of genes which are uniquely regulated by nitric oxide as a mechanism of promoting aggressive cancers. This work contributed to identifying druggable targets for metastatic triple negative breast cancer.

Prior to graduate school, Hannah received her bachelor’s degree in biochemistry with a minor in mathematics from Olivet Nazarene University. During her undergraduate studies, Hannah worked for biotechnology company CSL Behring as a quality control scientist where she contributed to developing and executing novel endotoxin detection methods for plasma-based therapeutics.

  • Ph.D., Pharmaceutical Sciences, University of Illinois at Chicago
  • B.S., Biochemistry, Olivet Nazarene University